Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation

NCT01574716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Soft Tissue Sarcoma

Interventions

DRUG: MORAb-004
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Placebo

Sponsor

Morphotek